ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer with poor clinical outcome, which is characterized by the lack of three targeted proteins: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2) 3.